SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $355,715 | -77.9% | 401,484 | -60.9% | 0.00% | -100.0% |
| Q3 2022 | $1,612,000 | +181.3% | 1,026,474 | +260.4% | 0.00% | +100.0% |
| Q2 2022 | $573,000 | -13.7% | 284,803 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $664,000 | -47.3% | 285,022 | +5.3% | 0.00% | 0.0% |
| Q4 2021 | $1,259,000 | -41.3% | 270,753 | -3.8% | 0.00% | 0.0% |
| Q3 2021 | $2,146,000 | -42.2% | 281,314 | -26.6% | 0.00% | -50.0% |
| Q2 2021 | $3,711,000 | +133.2% | 383,003 | +99.0% | 0.00% | +100.0% |
| Q1 2021 | $1,591,000 | -48.6% | 192,421 | -57.6% | 0.00% | -50.0% |
| Q4 2020 | $3,097,000 | -31.1% | 453,852 | +12.6% | 0.00% | -33.3% |
| Q3 2020 | $4,494,000 | +69.1% | 402,938 | -4.7% | 0.00% | +50.0% |
| Q2 2020 | $2,657,000 | +478.9% | 422,967 | +211.1% | 0.00% | – |
| Q4 2019 | $459,000 | +185.1% | 135,979 | +80.8% | 0.00% | – |
| Q3 2019 | $161,000 | -15.7% | 75,198 | +5.1% | 0.00% | – |
| Q2 2019 | $191,000 | -47.5% | 71,530 | -7.0% | 0.00% | – |
| Q1 2019 | $364,000 | +127.5% | 76,878 | +14.9% | 0.00% | – |
| Q4 2018 | $160,000 | -42.4% | 66,919 | +6.0% | 0.00% | – |
| Q3 2018 | $278,000 | -47.4% | 63,125 | -14.1% | 0.00% | -100.0% |
| Q2 2018 | $529,000 | +1002.1% | 73,529 | +508.1% | 0.00% | – |
| Q1 2017 | $48,000 | -43.5% | 12,092 | -30.9% | 0.00% | – |
| Q4 2016 | $85,000 | -24.1% | 17,510 | +21.4% | 0.00% | – |
| Q3 2016 | $112,000 | +19.1% | 14,419 | -13.5% | 0.00% | – |
| Q2 2016 | $94,000 | +30.6% | 16,665 | +24.4% | 0.00% | – |
| Q1 2016 | $72,000 | -39.0% | 13,394 | -1.2% | 0.00% | – |
| Q4 2015 | $118,000 | +3.5% | 13,553 | -0.2% | 0.00% | – |
| Q3 2015 | $114,000 | -49.6% | 13,575 | +5.7% | 0.00% | – |
| Q2 2015 | $226,000 | -67.2% | 12,840 | -78.4% | 0.00% | -100.0% |
| Q1 2015 | $689,000 | +185.9% | 59,532 | +216.7% | 0.00% | – |
| Q1 2014 | $241,000 | – | 18,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |